Nachrichten zur ANI Pharmaceuticals Inc. Aktie

ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Call Transcript

…

Aurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call Transcript

…

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET

BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today…

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharma granted FDA nod for generic Estradiol Gel

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Announces Approval, Launch Of Estradiol Gel, 0.1%

WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) received U.S. Food and Drug Administration approval for the Abbreviated New Drug Application…

ANI Pharmaceuticals Gets FDA Approval For Estradiol Gel

ANI Pharmaceuticals Gets FDA Approval For Estradiol Gel...…

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

BAUDETTE, Minn., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

-- Mr. Leonard is an accomplished leader with 35 years of pharmaceuticals and healthcare experience...…

Form 8-K ANI PHARMACEUTICALS INC For: Aug 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 1.361.976$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-08-15...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 1.705.474$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-08-14...…

Insiderhandel: Insider verkauft Aktien von ANI Pharmaceuticals im Wert von 11.700.000$

Meridian Venture Partners II Lp - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-08-16...…

Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year?

Here is how Amphastar Pharmaceuticals (AMPH) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year....…

ANI Pharmaceuticals (ANIP) Beats Q2 Earnings and Revenue Estimates

ANI (ANIP) delivered earnings and revenue surprises of 100% and 20.41%, respectively, for the quarter ended June 2023. Do the…

ANI Pharmaceuticals, Inc. Q2 Earnings Summary

WASHINGTON (dpa-AFX) - Below are the earnings highlights for ANI Pharmaceuticals, Inc. (ANIP):Earnings: $5.84 million in Q2 vs. -$15.33 million…

Form 10-Q ANI PHARMACEUTICALS INC For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Non-GAAP EPS of $1.28 beats by $0.61, revenue of $116.5M beats by $16.64M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ANI PHARMACEUTICALS INC For: Aug 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance  

Second Quarter 2023 Financial Results...…

ANI Pharmaceuticals Q2 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET

BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today…

ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know

ANI Pharmaceuticals (ANIP) closed the most recent trading day at $52.79, moving +1.15% from the previous trading session....…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 307.284$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-19...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 309.120$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-20...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 604.440$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-21...…

Where ANI Pharmaceuticals Stands With Analysts

Latest Ratings for ANIP DateFirmActionFromTo Nov 2021Raymond JamesMaintainsOutperform Nov 2021Truist SecuritiesInitiates Coverage OnBuy May 2021Raymond JamesMaintainsOutperform …

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 347.328$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-18...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 504.300$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-14...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 501.971$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-17...…

ANI Pharmaceuticals (ANIP) Gains But Lags Market: What You Should Know

In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $51.30, marking a +0.33% move from the previous day....…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 1.522.276$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-06-20...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 514.900$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-06-23...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 1.230.488$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-06-21...…

Insiderhandel: SVP - CORP. DEV. & STRATEGY verkauft Aktien von ANI Pharmaceuticals im Wert von 1.026.400$

Gassert, Chad - Vorstand - Tag der Transaktion: 2023-06-22...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 1.387.260$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-06-22...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 615.244$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-06-21...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 693.630$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-06-22...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 761.138$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-06-20...…

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Here is how ANI Pharmaceuticals (ANIP) and Cardiol Therapeutics Inc. (CRDL) have performed compared to their sector so far this…

Form 8-K ANI PHARMACEUTICALS INC For: Jun 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Bellerophon Therapeutics (BLPH) Outperforming Other Medical Stocks This Year?

Here is how Bellerophon Therapeutics (BLPH) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year....…

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Here is how ANI Pharmaceuticals (ANIP) and Compugen (CGEN) have performed compared to their sector so far this year....…

Form 8-K ANI PHARMACEUTICALS INC For: May 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution

WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for…

ANI Pharma gains as FDA clears generics for Celontin and Fosamax

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ANI PHARMACEUTICALS INC For: May 11

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals down 6%, prices $75M offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals announces proposed stock offering, shares fall 6% after hours

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…